EARNINGS PER COMMON SHARE

9 Months Ended

Sep. 30, 2021

The computation of basic and diluted earnings per common share for the three and nine months ended September 30, 2021 and 2020 were as follows:


Basic Earnings (Loss) Per Common Share	Three Months Ended				Nine Months Ended
(in millions, except per share amounts)	2021		2020		2021		2020

Net income (loss) attributable to Dentsply Sirona	$	84	$	47	$	292	$	(178)

Weighted average common shares outstanding	218.6		218.5		218.6		219.4

Earnings (loss) per common share - basic	$	0.39	$	0.22	$	1.34	$	(0.81)

Diluted Earnings (Loss) Per Common Share	Three Months Ended				Nine Months Ended
(in millions, except per share amounts)	2021		2020		2021		2020

Net income (loss) attributable to Dentsply Sirona	$	84	$	47	$	292	$	(178)

Weighted average common shares outstanding	218.6		218.5		218.6		219.4
Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards	1.9		0.7		2.1		—
Total weighted average diluted shares outstanding	220.5		219.2		220.7		219.4

Earnings (loss) per common share - diluted	$	0.38	$	0.22	$	1.32	$	(0.81)

For the three and nine months ended September 30, 2021, the Company excluded from the computation of weighted average diluted shares outstanding 0.9 million and 0.9 million, respectively, of equivalent shares of common stock from stock options and RSUs because their effect would be antidilutive. For the three and nine months ended September 30, 2020, the Company excluded 3.5 million and 3.2 million, respectively, of equivalent shares of common stock outstanding from stock options and RSUs because their effect would be antidilutive.

The calculation of weighted average diluted common shares outstanding excluded 0.9 million of potentially diluted common shares because the Company reported a net loss for the nine months ended September 30, 2020.

During the nine months ended September 30, 2021, the Company repurchased approximately 1.5 million shares pursuant to its open market shares repurchase plan for a net cost of $90 million at an average price of $60.62.

On July 28, 2021, the Board of Directors of the Company approved an increase in the value of shares of common stock that may be repurchased under the share repurchase program, up to $1.0 billion. Share repurchases may be made through open market purchases, Rule 10b5-1 plans, accelerated share repurchases, privately negotiated transactions or other transactions in such amounts and at such times as the Company deems appropriate based upon prevailing market and business conditions and other factors.